$AGYP green on huge oil news! (Allied Energy Acquires The

New Post Public Reply Private Reply Replies (0) Message Board
AyaStocks
212
$AGYP green on huge oil news! ( Allied Energy Acquires The Prometheus Lease )

OTC Energy Report: PVRS, IGPG, EUENF, PDGO, AGYP
OTC Oil and gas investors may also want to look at Allied Energy Corp. (OTCMKTS:AGYP) as it begins pumping oil from wells in Texas. While energy price and demand reach record highs, AGYP is an independent that has literally struck oil and has started pumping barrels when domestic buyers need it most. AGYP finished up 10% in Monday’s trading and there is a large short position which has investors paying close attention to this one.

Trending Stocks Today: AGYP
Oil prices continue to rise at alarming rates amidst the global economic recovery. Now, US oil prices have reached their highest price in 7 years, surpassing the $80 mark. While this is bad news for consumers, it is one of the biggest catalysts to hit the oil market and the anticipated surge in oil stock prices is making them some of the most trending stocks today. As tensions grow between the US government and OPEC+, domestic oil producing companies are becoming center stage. Allied Energy Corporation (OTC: AGYP) is one such example, shooting up 30% on Monday morning before closing up 13% despite a generally red market.

Catalysts
An energy crisis is gripping the world’s largest economies as the supply remains significantly below demand. The conservative OPEC+ production numbers come as a reactionary measure to the collapse in oil prices at the beginning of the pandemic. Despite warnings by large organizations such as Goldman Sachs that oil might soon reach $90 a barrel by the EOY, OPEC+ representatives continue to stress that the price surge is not significant enough to change course.

Meanwhile AGYP has continued making significant progress at their two domestic oil production sites. Recently sharing videos for their Green Lease Site, AGYP’s onsite team have installed pumpjacks and a saltwater disposal well. This was in accordance with the Texas Railroad Commission which recently observed the H-5 Casing integrity test on the Green lease saltwater Disposal Well. This is an important step forward for the company which must be able to pump down the water in order to publish fairly accurate barrels per day estimates.

Clearly OPEC’s firm stance will continue helping domestic oil producing companies like AGYP as long as the Biden administration remains at odds with OPEC. The demand for domestically sourced oil will likely skyrocket which is good for AGYP as its recent report revealed considerable petroleum estimates for both sites.

According to the report’s results, the Green Lease site is believed to have 229,400 “probable” barrels of oil and 448,000 “possible” barrels. While the Annie Gilmer is expected to have 80,400 “probable” barrels of oil and 135,500 “possible” barrels of oil.

AGYP has witnessed an over 500% increase since the beginning of 2021. With this progress in mind, AGYP’s CEO George Montieth shared that “Allied is now on the cusp of becoming a producing oil company”. But the volatile global energy situation remains a significant catalyst for AGYP and will continue making oil stocks some of the most trending stocks today.

Amidst all of this, AGYP uploaded three videos on September 8th, showing their work on the Green Lease project. Each video proved that AGYP is not all talk and investors’ excitement peaked with this information. In the days following, AGYP’s share value rose rapidly thanks to bullish investors. Its stock will likely continue to play in sympathy with oil demand and market fluctuations which is an important catalyst for investors trading AGYP.

Media Sentiment
An explosion is imminent indeed as @LadeBackk points out. Oil stocks are bound to hit all-time-highs!
https://twitter.com/LadeBackk/status/14450763...s-today%2F

Technical Analysis
AGYP_2021-10-05_12-39-22-1.png
Currently trading at $0.3312, AGYP has a resistance line at .4283. The primary support line lies at .3097 and its secondary support lies at .3003. There has been a slight dip in accumulation recently, however the MACD remains strong after recently witnessing a bullish crossover. The RSI currently stands at 61.79.

Should You Buy?
With a seemingly firm position by OPEC+, and a global shortage in oil production, investing in AGYP seems to be pretty straightforward as oil stocks being the most trending stocks today. With oil production well underway on AGYP sites, and domestic oil demand rising, AGYP stock is likely to rise. However, it is important for investors to note that the oil sector comes with high volatility. AGYP has been having a tremendous year, with a rise of over 500%, and is likely to hit its resistance line very soon.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

China's Manufacturing: Squeeze or Opportunity?

Updated Category News Views 1

Analyzing China's Impact on Global Markets Think of China's manufacturing clout and you're likely to picture booming factories, relentless steel, and smoke-churning industries reshaping the global chessboard. But here's the kicker: are they swallowing up room for others, or paving the way for their growth? It’s this debate that took the spotlight at the Asia-Pacific...

Continue Reading
Pudu D7 Robot Shines at IFA, Setting New Robotics Bar

Updated Category News Views 2

Breaking New Ground in Robotics at IFA Well, here's a nugget for robotics buffs and investors alike: Pudu Robotics, a heavyweight in commercial service robotics, is carving out a fresh chapter with its PUDU D7. Making waves as an honoree at the IFA Innovation Awards, the D7 presents a mash-up of brains and brawn—exemplifying the future path for robotics. The PUDU D7...

Continue Reading
Changhong's IFA 2026 Showcase: AI, Culture & Localization

Updated Category News Views 3

Changhong's Game Plan: From Global Reach to Local Touch Well, Changhong's not sitting back at IFA 2026, let me tell you that. This isn't your run-of-the-mill showcase; it's a full-on reveal of what happens when a company takes AI tech and tunes it to the heartbeat of daily life. TVs, fridges, air conditioners—you name it, they've got an AI twist on it. But is this just...

Continue Reading
Morpho Unveils Versatile UV Printer at IFA 2026

Updated Category News Views 4

IFA 2026: A New Frontier for Desktop Printing You've seen your fair share of printers over the years, but when a company like Morpho steps onto the scene with a gadget that echoes innovation, it makes you perk up those market-ears. We're talking the big unveil of their desktop UV printer at the IFA 2026 in Berlin. Morpho's contraption isn't just spewing out ink; it's...

Continue Reading
York Space Systems Faces Class Action Over Misleading IPO

Updated Category News Views 2

York Space Systems Under the Legal Spotlight Ever get that feeling when something just doesn’t sit right? Like a burr under the saddle, York Space Systems is now grappling with a class action lawsuit that's throwing a heap of shade on its recent moves. What’s at play? Bronstein, Gewirtz & Grossman, LLC, a law firm that seems to have a nose for corporate messes, has...

Continue Reading
Roborock Fuels Market Surge with 27.6% Revenue Boost

Updated Category News Views 1

Roborock's Rocket-Like Ascent in Global Markets Call me impressed, but Roborock is really hitting its stride. The company's been on a tear, pulling in RMB 10.084 billion during the first half of 2026—a remarkable 27.6% bump from last year. Not just content with the revenue surge, they also saw net profits jump 45.6%, making it pretty clear that they're not just playing...

Continue Reading
Hims & Hers Faces Class Action: Investors Beware

Updated Category News Views 1

Allegations and Legal Pressure There's trouble brewing in the land of health and wellness apps, with Hims & Hers Health, Inc. (NYSE:HIMS) taking center stage. Slap on your glasses, folks, because this one's a doozy. A class-action lawsuit has exploded against the company and some of its officers—allegations flying as they focus on serious accusations of misleading...

Continue Reading
EyePoint Stumbles: Legal Eagles Circle Post-Trial Flop

Updated Category News Views 1

EyePoint Slips on Clinical Banana Peel Well, if EyePoint was aiming for a splash, they sure got it—just not the kind they were hoping for. News dropped like a lead balloon when EyePoint announced their Phase 3 DURAVYU trial results for wet age-related macular degeneration, revealing they missed their primary endpoint. And what did that mean for their stock? A death...

Continue Reading
LiberNovo Demos Ergonomic Seating at IFA 2026

Updated Category News Views 3

Riding the Ergonomic Wave at IFA 2026 No stranger to the innovation spotlight, LiberNovo’s got its eyes on Berlin this time around. As sparks fly at the IFA 2026, they’re rolling out their grand Maxis Series and rubbing shoulders with big names in technology. How does a company shake things up in a sea of tech? Start by thinking big and tall—literally. Maxis Series:...

Continue Reading
See's Candies Data Breach Spurs Legal Scrutiny

Updated Category News Views 12

Data Breach Hits See's Candies Hard Amidst Ransomware Attack Alright, folks, here's a not-so-sweet tale to kick off your day — See's Candies has found itself in a bit of a pickle. A ransomware attack, the nasty kind that makes you double-check your locks and your passwords, has reportedly exposed the personal data of its customers and employees. We're talking names,...

Continue Reading

Top 5 Most Recently Viewed Articles

Hoyne Bancorp's Transition to Stock Holding Company Explained

Updated Category News Views 240

Hoyne Bancorp, Inc. Announces Conversion Approval Hoyne Bancorp, Inc., a leading financial institution, has recently completed a significant milestone in its evolution. This marks an important phase as the organization transitions from a mutual holding company to a stock holding company, a move that is poised to enhance its operational framework. By transforming into a...

Continue Reading
Incyte's INCB123667 Demonstrates Promise for Ovarian Cancer

Updated Category News Views 133

Incyte's Advancements with INCB123667 Incyte, a forward-thinking biopharmaceutical company known for its innovative therapies, has revealed promising early-stage clinical results for its CDK2 inhibitor, INCB123667. This potential game-changer is designed to target advanced solid tumors, particularly ovarian cancer, where there are still significant unmet medical needs....

Continue Reading
GCL SI Highlights Innovations and Solutions for Solar Energy

Updated Category News Views 167

GCL SI Showcases Innovations at Intersolar Europe At Intersolar Europe 2025, GCL System Integration (GCL SI) presents groundbreaking technologies and comprehensive solar solutions, demonstrating its significant role in photovoltaic advancement. From cutting-edge granular silicon to high-efficiency perovskite modules, GCL is at the forefront of global decarbonization...

Continue Reading
8x8, Inc. Celebrates Inclusion in Newsweek's Excellence Ranking

Updated Category News Views 177

8x8, Inc. Recognized by Newsweek for Corporate Excellence 8x8, Inc. (NASDAQ: EGHT) has recently been acknowledged in the prestigious Excellence 1000 Index published by Newsweek. This esteemed ranking celebrates companies demonstrating outstanding practices in various crucial areas such as financial responsibility and social accountability. Understanding the Excellence...

Continue Reading
James Hardie Industries Faces Leadership Change Amid Lawsuit

Updated Category News Views 183

James Hardie Industries Faces Leadership Turmoil Recently, James Hardie Industries plc (NYSE: JHX) announced a significant leadership transition with the departure of its Chief Financial Officer, Rachel Wilson. Ryan Lada has been brought in as her replacement. This change comes in the wake of troubling developments concerning the company's financial practices and investor...

Continue Reading